Breast implant-associated anaplastic large-cell lymphoma (BIA-ALCL)
Breast implant-associated anaplastic large-cell lymphoma (BIA-ALCL) is a rare T-cell non-Hodgkin lymphoma characterized as CD30 positive and anaplastic lymphoma kinase (ALK) negative. In 2016, the World Health Organization declared BIA-ALCL as a new disease entity. The first case of BIA-ALCL was rep...
Main Author: | Jun-Ho Lee |
---|---|
Format: | Article |
Language: | English |
Published: |
Yeungnam University College of Medicine
2021-07-01
|
Series: | Yeungnam University Journal of Medicine |
Subjects: | |
Online Access: | http://www.e-yujm.org/upload/pdf/yujm-2020-00801.pdf |
Similar Items
-
Synchronous breast implant associated anaplastic large cell lymphoma (BIA-ALCL) and silicone induced granuloma of breast implant capsule (SIGBIC): What to learn
by: Eduardo de Faria Castro Fleury, MD, PhD, and Post-Doctorate
Published: (2020-10-01) -
Is breast implant-associated anaplastic large cell lymphoma a hazard of breast implant surgery?
by: Florian Fitzal, et al.
Published: (2019-04-01) -
The State of the Art about Etiopathogenetic Models on Breast Implant Associated–Anaplastic Large Cell Lymphoma (BIA-ALCL): A Narrative Review
by: Roberto Cuomo
Published: (2021-05-01) -
The Pathological Spectrum of Systemic Anaplastic Large Cell Lymphoma (ALCL)
by: Ivonne A. Montes-Mojarro, et al.
Published: (2018-04-01) -
Breast implant-associated anaplastic large cell lymphoma (BIA-ALCL) – The first case in Taiwan
by: Chih-Sheng Lai, et al.
Published: (2021-06-01)